Literature DB >> 23541519

V(H)H (nanobody) directed against human glycophorin A: a tool for autologous red cell agglutination assays.

Ibrahim Habib1, Dorota Smolarek, Claude Hattab, Magdalena Grodecka, Gholamreza Hassanzadeh-Ghassabeh, Serge Muyldermans, Sandrine Sagan, Carlos Gutiérrez, Syria Laperche, Caroline Le-Van-Kim, Yves Colin Aronovicz, Kazimiera Wasniowska, Stephane Gangnard, Olivier Bertrand.   

Abstract

The preparation of a V(H)H (nanobody) named IH4 that recognizes human glycophorin A (GPA) is described. IH4 was isolated by screening a library prepared from the lymphocytes of a dromedary immunized by human blood transfusion. Phage display and panning against GPA as the immobilized antigen allowed isolating this V(H)H. IH4, representing 67% of the retrieved V(H)H sequences, was expressed as a soluble correctly folded protein in SHuffle Escherichia coli cells, routinely yielding approximately 100 mg/L fermentation medium. Because IH4 recognizes GPA independently of the blood group antigens, it recognizes red cells of all humans with the possible exception of those with some extremely rare genetic background. The targeted linear epitope comprises the GPA Y52PPE55 sequence. Based on surface plasmon resonance results, the dissociation constant of the IH4-GPA equilibrium is 33 nM. IH4 is a stable protein with a transition melting temperature of 75.8 °C (measured by differential scanning calorimetry). As proof of concept, we fused HIV p24 to IH4 and used the purified construct expressed in E. coli to show that IH4 was amenable to the preparation of autologous erythrocyte agglutination reagents: reconstituted blood prepared with serum from an HIV-positive patient was readily agglutinated by the addition of the bifunctional reagent.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541519     DOI: 10.1016/j.ab.2013.03.020

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

1.  DARC, Glycophorin A, Band 3, and GLUT1 Diffusion in Erythrocytes: Insights into Membrane Complexes.

Authors:  Gayani C Kodippili; Katie Giger; Karson S Putt; Philip S Low
Journal:  Biophys J       Date:  2020-09-23       Impact factor: 4.033

2.  Diffusion of glycophorin A in human erythrocytes.

Authors:  Katie Giger; Ibrahim Habib; Ken Ritchie; Philip S Low
Journal:  Biochim Biophys Acta       Date:  2016-08-28

Review 3.  Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.

Authors:  Yongzhong Wang; Zhen Fan; Lei Shao; Xiaowei Kong; Xianjuan Hou; Dongrui Tian; Ying Sun; Yazhong Xiao; Li Yu
Journal:  Int J Nanomedicine       Date:  2016-07-21

4.  Nanobody-mediated resistance to Grapevine fanleaf virus in plants.

Authors:  Caroline Hemmer; Samia Djennane; Léa Ackerer; Kamal Hleibieh; Aurélie Marmonier; Sophie Gersch; Shahinez Garcia; Emmanuelle Vigne; Véronique Komar; Mireille Perrin; Claude Gertz; Lorène Belval; François Berthold; Baptiste Monsion; Corinne Schmitt-Keichinger; Olivier Lemaire; Bernard Lorber; Carlos Gutiérrez; Serge Muyldermans; Gérard Demangeat; Christophe Ritzenthaler
Journal:  Plant Biotechnol J       Date:  2017-10-06       Impact factor: 9.803

Review 5.  Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction.

Authors:  Weina Ma; Liu Yang; Langchong He
Journal:  J Pharm Anal       Date:  2018-05-05

6.  High Expression Achievement of Active and Robust Anti-β2 microglobulin Nanobodies via E.coli Hosts Selection.

Authors:  Da Li; Fangling Ji; Chundong Huang; Lingyun Jia
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

7.  Removal of a Conserved Disulfide Bond Does Not Compromise Mechanical Stability of a VHH Antibody Complex.

Authors:  Haipei Liu; Valentin Schittny; Michael A Nash
Journal:  Nano Lett       Date:  2019-07-05       Impact factor: 11.189

8.  A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.

Authors:  Alain Townsend; Pramila Rijal; Julie Xiao; Tiong Kit Tan; Kuan-Ying A Huang; Lisa Schimanski; Jiandong Huo; Nimesh Gupta; Rolle Rahikainen; Philippa C Matthews; Derrick Crook; Sarah Hoosdally; Susanna Dunachie; Eleanor Barnes; Teresa Street; Christopher P Conlon; John Frater; Carolina V Arancibia-Cárcamo; Justine Rudkin; Nicole Stoesser; Fredrik Karpe; Matthew Neville; Rutger Ploeg; Marta Oliveira; David J Roberts; Abigail A Lamikanra; Hoi Pat Tsang; Abbie Bown; Richard Vipond; Alexander J Mentzer; Julian C Knight; Andrew J Kwok; Gavin R Screaton; Juthathip Mongkolsapaya; Wanwisa Dejnirattisai; Piyada Supasa; Paul Klenerman; Christina Dold; J Kenneth Baillie; Shona C Moore; Peter J M Openshaw; Malcolm G Semple; Lance C W Turtle; Mark Ainsworth; Alice Allcock; Sally Beer; Sagida Bibi; Donal Skelly; Lizzy Stafford; Katie Jeffrey; Denise O'Donnell; Elizabeth Clutterbuck; Alexis Espinosa; Maria Mendoza; Dominique Georgiou; Teresa Lockett; Jose Martinez; Elena Perez; Veronica Gallardo Sanchez; Giuseppe Scozzafava; Alberto Sobrinodiaz; Hannah Thraves; Etienne Joly
Journal:  Nat Commun       Date:  2021-03-29       Impact factor: 14.919

9.  Llama immunization with full-length VAR2CSA generates cross-reactive and inhibitory single-domain antibodies against the DBL1X domain.

Authors:  Sofia Nunes-Silva; Stéphane Gangnard; Marta Vidal; Anneleen Vuchelen; Sebastien Dechavanne; Sherwin Chan; Els Pardon; Jan Steyaert; Stephanie Ramboarina; Arnaud Chêne; Benoît Gamain
Journal:  Sci Rep       Date:  2014-12-09       Impact factor: 4.379

10.  Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors.

Authors:  Elena Barbon; Gabriel Ayme; Federico Mingozzi; Peter J Lenting; Amel Mohamadi; Jean-François Ottavi; Charlotte Kawecki; Caterina Casari; Sebastien Verhenne; Solenne Marmier; Laetitia van Wittenberghe; Severine Charles; Fanny Collaud; Cecile V Denis; Olivier D Christophe
Journal:  EMBO Mol Med       Date:  2020-03-11       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.